Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids.

M'baya-Moutoula E, Marchand A, Six I, Bahrar N, Celic T, Mougenot N, Maitrias P, Massy ZA, Lompre AM, Metzinger L, Metzinger-Le Meuth V.

Curr Vasc Pharmacol. 2019 Jul 5. doi: 10.2174/1570161117666190705141152. [Epub ahead of print]

PMID:
31284864
2.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Jun 14. pii: gfz089. doi: 10.1093/ndt/gfz089. [Epub ahead of print]

PMID:
31197325
3.

Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy.

Aubert CE, Liabeuf S, Amouyal C, Kemel S, Lajat-Kiss F, Lacorte JM, Halbron M, Carlier A, Salem JE, Funck-Brentano C, Perisic Matic L, Witasp A, Stenvinkel P, Phan F, Massy ZA, Hartemann A, Bourron O.

Diabetol Metab Syndr. 2019 Apr 29;11:32. doi: 10.1186/s13098-019-0429-7. eCollection 2019.

4.

Erratum.

Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2019 May 18. pii: gfz112. doi: 10.1093/ndt/gfz112. [Epub ahead of print] No abstract available.

PMID:
31102523
5.

The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry.

Luxardo R, Kramer A, González-Bedat MC, Massy ZA, Jager KJ, Rosa-Diez G, Noordzij M; collaborators.

Rev Panam Salud Publica. 2018 Sep 7;42:e87. doi: 10.26633/RPSP.2018.87. eCollection 2018.

6.

Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets.

Favretto G, Cunha RSD, Dalboni MA, Oliveira RB, Barreto FC, Massy ZA, Stinghen AEM.

Toxins (Basel). 2019 May 13;11(5). pii: E267. doi: 10.3390/toxins11050267. Review.

7.

Vascular calcification - any place left for nicotinamide?

Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz057. doi: 10.1093/ndt/gfz057. [Epub ahead of print] No abstract available.

PMID:
31071218
8.

Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?

Lenglet A, Fabresse N, Taupin M, Gomila C, Liabeuf S, Kamel S, Alvarez JC, Drueke TB, Massy ZA.

Drugs. 2019 Jun;79(8):855-862. doi: 10.1007/s40265-019-01118-9.

PMID:
31062264
9.

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease.

Hénaut L, Grissi M, Brazier F, Assem M, Poirot-Leclercq S, Lenglet G, Boudot C, Avondo C, Boullier A, Choukroun G, Massy ZA, Kamel S, Chillon JM.

Sci Rep. 2019 Apr 23;9(1):6432. doi: 10.1038/s41598-019-42933-0.

10.

Erythropoiesis-Stimulating Agents and Mortality.

Drüeke TB, Massy ZA.

J Am Soc Nephrol. 2019 Jun;30(6):907-908. doi: 10.1681/ASN.2019030266. Epub 2019 Apr 23. No abstract available.

PMID:
31015256
11.

Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.

Laville SM, Stengel B, Massy ZA, Liabeuf S.

Br J Clin Pharmacol. 2019 Jun;85(6):1380-1381. doi: 10.1111/bcp.13924. Epub 2019 Apr 13. No abstract available.

PMID:
30980562
12.

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.

Ureña-Torres PA, Vervloet M, Mazzaferro S, Oury F, Brandenburg V, Bover J, Cavalier E, Cohen-Solal M, Covic A, Drüeke TB, Hindié E, Evenepoel P, Frazão J, Goldsmith D, Kazama JJ, Cozzolino M, Massy ZA; ERA-EDTA CKD-MBD Working Group.

Clin Kidney J. 2018 Jul 20;12(2):269-280. doi: 10.1093/ckj/sfy061. eCollection 2019 Apr.

13.

[Middle-molecule uremic toxins: A renewed interest].

Nlandu Y, Padden M, Seidowsky A, Hamaz S, Vilaine É, Cheddani L, Essig M, Massy ZA.

Nephrol Ther. 2019 Apr;15(2):82-90. doi: 10.1016/j.nephro.2018.09.003. French.

PMID:
30954165
14.

Guideline attainment and morbidity/mortality rates in a large cohort of European haemodialysis patients (EURODOPPS).

Liabeuf S, Sajjad A, Kramer A, Bieber B, McCullough K, Pisoni R, Caskey F, Combe C, Robinson BM, Jager KJ, Massy ZA.

Nephrol Dial Transplant. 2019 Apr 1. pii: gfz049. doi: 10.1093/ndt/gfz049. [Epub ahead of print]

PMID:
30938439
15.

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox.

Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8.

16.

The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.

Fotheringham J, Sajjad A, Stel VS, McCullough K, Karaboyas A, Wilkie M, Bieber B, Robinson BM, Massy ZA, Jager KJ.

Nephrol Dial Transplant. 2019 Feb 28. pii: gfz007. doi: 10.1093/ndt/gfz007. [Epub ahead of print]

17.

Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.

Belmokhtar K, Ortillon J, Jaisson S, Massy ZA, Boulagnon Rombi C, Doué M, Maurice P, Fritz G, Gillery P, Schmidt AM, Rieu P, Touré F.

Nephrol Dial Transplant. 2019 Feb 18. pii: gfz012. doi: 10.1093/ndt/gfz012. [Epub ahead of print]

PMID:
30778553
18.

Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study.

Schweitzer ML, Stengel B, Legrand K, Briançon S, Jacquelinet C, Combe C, Fouque D, Massy ZA, Laville M, Frimat L, Ayav C.

Qual Life Res. 2019 Jul;28(7):1873-1883. doi: 10.1007/s11136-019-02110-2. Epub 2019 Jan 18.

PMID:
30659448
19.

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R.

Int Urol Nephrol. 2019 Feb;51(2):293-302. doi: 10.1007/s11255-018-2056-x. Epub 2019 Jan 2.

PMID:
30604232
20.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
21.

International comparison of trends in patients commencing renal replacement therapy by primary renal disease.

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ.

Nephrology (Carlton). 2018 Nov 19. doi: 10.1111/nep.13531. [Epub ahead of print]

PMID:
30456883
22.

Hyponatremia and MAP-kinase inhibitors in malignant melanoma: Frequency, pathophysiological aspects and clinical consequences.

Assan F, Vilaine E, Wagner S, Longvert C, Saiag P, Seidowsky A, Bourgault-Villada I, Massy ZA.

Pigment Cell Melanoma Res. 2019 Mar;32(2):326-331. doi: 10.1111/pcmr.12749. Epub 2018 Nov 22.

PMID:
30387922
23.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
24.

Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche.

Aleksinskaya MA, Monge M, Siebelt M, Slot EM, Koekkoek KM, de Bruin RG, Massy ZA, Weinans H, Rabelink TJ, Fibbe WE, Jan van Zonneveld A, van Pel M.

Sci Rep. 2018 Oct 18;8(1):15385. doi: 10.1038/s41598-018-33979-7.

25.

Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions.

Maciel RAP, Cunha RS, Busato V, Franco CRC, Gregório PC, Dolenga CJR, Nakao LS, Massy ZA, Boullier A, Pecoits-Filho R, Stinghen AEM.

Toxins (Basel). 2018 Oct 7;10(10). pii: E404. doi: 10.3390/toxins10100404.

26.

From old uraemic toxins to new uraemic toxins: place of 'omics'.

Massy ZA, Liabeuf S.

Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii2-iii5. doi: 10.1093/ndt/gfy212.

27.

Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients ages 20-50 years: a study by the ERA-EDTA Registry.

Pippias M, Jager KJ, Åsberg A, Berger SP, Finne P, Heaf JG, Kerschbaum J, Lempinen M, Magaz Á, Massy ZA, Stel VS.

Nephrol Dial Transplant. 2018 Sep 7. doi: 10.1093/ndt/gfy268. [Epub ahead of print]

PMID:
30203080
28.

Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.

Villain C, Metzger M, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Briançon S, Klein J, Schanstra JP, Robinson BM, Mansencal N, Stengel B, Massy ZA; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Investigators .

Nephrol Dial Transplant. 2018 Aug 28. doi: 10.1093/ndt/gfy277. [Epub ahead of print]

PMID:
30169874
29.

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.

Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V.

Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.

PMID:
30122544
30.

Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Ayav C, Speyer E, Robinson BM, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Collaborators.

Br J Clin Pharmacol. 2018 Dec;84(12):2811-2823. doi: 10.1111/bcp.13738. Epub 2018 Sep 24.

PMID:
30110711
31.

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ.

J Thromb Haemost. 2018 Oct;16(10):1953-1963. doi: 10.1111/jth.14254. Epub 2018 Aug 22.

PMID:
30063819
32.

Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney Disease.

Puy L, Bugnicourt JM, Liabeuf S, Desjardins L, Roussel M, Diouf M, Chillon JM, Choukroun G, Massy ZA, Godefroy O.

J Neuropsychiatry Clin Neurosci. 2018 Fall;30(4):310-317. doi: 10.1176/appi.neuropsych.18030047. Epub 2018 Jul 26.

PMID:
30045680
33.

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Assem M, Lando M, Grissi M, Kamel S, Massy ZA, Chillon JM, Hénaut L.

Toxins (Basel). 2018 Jul 22;10(7). pii: E303. doi: 10.3390/toxins10070303. Review.

34.

Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study.

Geri G, Stengel B, Jacquelinet C, Aegerter P, Massy ZA, Vieillard-Baron A; PREDICT investigators.

Ann Intensive Care. 2018 Jul 6;8(1):77. doi: 10.1186/s13613-018-0421-7.

35.

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.

Liabeuf S, Cheddani L, Massy ZA.

Toxins (Basel). 2018 Jun 5;10(6). pii: E229. doi: 10.3390/toxins10060229. Review.

36.

The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.

Hénaut L, Mary A, Chillon JM, Kamel S, Massy ZA.

Toxins (Basel). 2018 May 29;10(6). pii: E218. doi: 10.3390/toxins10060218. Review.

37.

The expanding roles of microRNAs in kidney pathophysiology.

Metzinger-Le Meuth V, Fourdinier O, Charnaux N, Massy ZA, Metzinger L.

Nephrol Dial Transplant. 2019 Jan 1;34(1):7-15. doi: 10.1093/ndt/gfy140.

PMID:
29800482
38.

Magnesium as a Calcification Inhibitor.

Hénaut L, Massy ZA.

Adv Chronic Kidney Dis. 2018 May;25(3):281-290. doi: 10.1053/j.ackd.2017.12.001. Review.

PMID:
29793668
39.

Differential Determinants of Tubular Phosphate Reabsorption: Insights on Renal Excretion of Phosphates in Kidney Disease.

Tabibzadeh N, Mentaverri R, Daroux M, Mesbah R, Delpierre A, Paul JG, Deken V, Massy ZA, Bataille P.

Am J Nephrol. 2018;47(5):300-303. doi: 10.1159/000488864. Epub 2018 May 18.

PMID:
29779025
40.

A multi-omics analysis of the regulatory changes induced by miR-223 in a monocyte/macrophage cell line.

M'baya-Moutoula E, Louvet L, Molinié R, Guerrera IC, Cerutti C, Fourdinier O, Nourry V, Gutierrez L, Morlière P, Mesnard F, Massy ZA, Metzinger-Le Meuth V, Metzinger L.

Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2664-2678. doi: 10.1016/j.bbadis.2018.05.010. Epub 2018 May 17. No abstract available.

PMID:
29778662
41.

Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease.

Hénaut L, Chillon JM, Kamel S, Massy ZA.

Semin Nephrol. 2018 May;38(3):233-250. doi: 10.1016/j.semnephrol.2018.02.004. Review.

PMID:
29753400
42.

Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.

Helve J, Kramer A, Abad-Diez JM, Couchoud C, de Arriba G, de Meester J, Evans M, Glaudet F, Grönhagen-Riska C, Heaf JG, Lezaic V, Nordio M, Palsson R, Pechter Ü, Resic H, Santamaria R, Santiuste de Pablos C, Massy ZA, Zurriaga Ó, Jager KJ, Finne P.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435. doi: 10.1093/ndt/gfy056.

PMID:
29684185
43.

Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.

Stengel B, Metzger M, Combe C, Jacquelinet C, Briançon S, Ayav C, Fouque D, Laville M, Frimat L, Pascal C, Herpe YE, Morel P, Deleuze JF, Schanstra JP, Lange C, Legrand K, Speyer E, Liabeuf S, Robinson BM, Massy ZA.

Nephrol Dial Transplant. 2019 Feb 1;34(2):277-286. doi: 10.1093/ndt/gfy058.

PMID:
29635335
44.

[Pulmonary ultrasound and dialysis].

Seidowsky A, Vilaine È, Mansencal N, Ébel A, Villain C, Cheddani L, Massy ZA.

Nephrol Ther. 2018 Apr;14 Suppl 1:S73-S81. doi: 10.1016/j.nephro.2018.02.013. French.

PMID:
29606266
45.

The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary.

Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Ambühl PM, Andrusev AM, Fuster EA, Arribas Monzón FE, Åsberg A, Barbullushi M, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, des Grottes JM, Garneata L, Golan E, Hemmelder MH, Ioannou K, Jarraya F, Kolesnyk M, Komissarov K, Lassalle M, Macario F, Mahillo-Duran B, Martín de Francisco AL, Palsson R, Pechter Ü, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Simic Ogrizovic S, Slon Roblero MF, Spustova V, Stojceva-Taneva O, Traynor J, Massy ZA, Jager KJ.

Clin Kidney J. 2018 Feb;11(1):108-122. doi: 10.1093/ckj/sfx149. Epub 2018 Jan 5.

46.

New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease.

Hénaut L, Massy ZA.

Nephrol Dial Transplant. 2018 Apr 1;33(4):543-548. doi: 10.1093/ndt/gfx379. No abstract available.

PMID:
29420799
47.

Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry.

Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1794-1804. doi: 10.1093/ndt/gfx355.

PMID:
29361126
48.

Performance of an easy-to-use prediction model for renal patient survival: an external validation study using data from the ERA-EDTA Registry.

Hemke AC, Heemskerk MBA, van Diepen M, Kramer A, de Meester J, Heaf JG, Abad Diez JM, Torres Guinea M, Finne P, Brunet P, Vikse BE, Caskey FJ, Traynor JP, Massy ZA, Couchoud C, Groothoff JW, Nordio M, Jager KJ, Dekker FW, Hoitsma AJ.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1786-1793. doi: 10.1093/ndt/gfx348.

PMID:
29346645
49.

Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients.

Duranton F, Kramer A, Szwarc I, Bieber B, Gayrard N, Jover B, Vetromile F, Massy ZA, Combe C, Tentori F, Jager KJ, Servel MF, Argilés À.

Hypertension. 2018 Feb;71(2):289-296. doi: 10.1161/HYPERTENSIONAHA.117.10274. Epub 2017 Dec 18.

PMID:
29255071
50.

Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry.

Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS.

Transpl Int. 2018 Jul;31(7):708-719. doi: 10.1111/tri.13103. Epub 2017 Dec 21.

Supplemental Content

Loading ...
Support Center